alexa Pharmacokinetics, Metabolism and Excretion of Hypolipidemic DRUG: 16-Dehydropregnenolone
ISSN: 2157-7609

Journal of Drug Metabolism & Toxicology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

Pharmacokinetics, Metabolism and Excretion of Hypolipidemic DRUG: 16-Dehydropregnenolone

Pratima Srivastava1*, Neha Mathur1 and Ashim Ghatak2

1Division of Pharmacokinetics and Drug Metabolism and CSIR-Central Drug Research Institute Sector 10, Jankipuram Extension, Sitapur Road, Lucknow-226031, UP,India

2Clinical and Experimental Medicine Division, CSIR-Central Drug Research Institute Sector 10, Jankipuram Extension, Sitapur Road, Lucknow-226031, UP, India

*Corresponding Author:
Pratima Srivastava
Division of Pharmacokinetics and Drug Metabolism and CSIR-Central Drug Research Institute Sector 10
Jankipuram Extension
Sitapur Road, Lucknow-226031
UP, India
Tel: 919000232335
E-mail: [email protected]

Received date: August 29, 2013; Accepted date: October 26, 2013; Published date: October 28, 2013

Citation: Srivastava P, Mathur N, Ghatak A (2013) Pharmacokinetics, Metabolism and Excretion of Hypolipidemic DRUG: 16 -Dehydropregnenolone. J Drug Metab Toxicol 4:158. doi: 10.4172/2157-7609.1000158

Copyright: © 2013 Srivastava P, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 

Abstract

Purpose: 16-dehydropregnenolone/DHP/CDRI-80/574, a new orally effective hypolipidemic agent presently in advanced clinical trials. This paper aims to study the absorption, distribution, metabolism and excretion profiles in order to delineate the possible cause(s) behind low bioavailability of CDRI-80/574 and also strategy to enhance the same. "
Methods: Metabolic, Excretion and Pharmacokinetics studies were conducted in the Sprague-Dawley rats.
Results: CDRI-80/574 exhibited log D: 4.5, absorption-half-life of 18 min and -constant 0.04/min by closed loop intestinal model in rats, was stable in gastric juice and 30% of RBCs transport/uptake was noted. CDRI-80/574 undergoes rapid metabolism in rat hepatic microsomal fractions; however extra hepatic tissues (intestinal-wall and -microvilli), showed less metabolism. IC50 of CDRI-80/574 was 2.22 nM, Km =15.8 nM, Vmax= 0.46 nmoles/mg protein/min, t1/2 was 3 min in microsomes. CDRI-80/574 was comparatively more stable in human hepatocytes (t1/2= 8.7 min) than rats (t1/2= 4.6 min). Aminobenzotriazole, ketoconazole, diltiazem and grapefruit juice inhibited CDRI- 80/574 metabolism, whereas, its metabolism was induced by phenobarbitone. Epoxy metabolite of CDRI-80/574 was synthesized and characterized. About 15% of CDRI-80/574 and 4 metabolites (hydrolysis/hydroxylation; m/z 317/319/321/330) were detected in feces. CDRI–80/574 was 7% bioavailable and exposure increased (2 fold) by grapefruit juice. Human CLinvivo was predicted to be 2.7 L/h/kg (45.83 ml/min/kg) by allometric scaling.
Conclusion: CDRI-80/574 is the first hypolipidemic, synthetic compound of pregnane series, hence it is important to elucidate the major reason for its low bioavailability. The compound was fast metabolized by CYP3A4. Further the inhibitors of CYP3A4 were able to increase the bioavailability of CDRI-80/574.

Keywords

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords